2023-504690-21-00Not yet recruitingPhase 1
Oxytocine and migraine
Source: EU CTIS (euclinicaltrials.eu) · Last updated 22 Oct 2025 · Not updated for over 12 months - ask the site whether it is still open
- Status (registry)
- Not yet recruiting
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- First submitted
- 17 Mar 2025
- Start date
- 1 May 2025
- Lead sponsor
- Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
- Diseases
- Migraine
- EU CT number
- 2023-504690-21-00
What you commit to
- Study type: Interventional · Phase 1
- Planned participants: 30
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
AI-kivonat: who the study is looking for
Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for healthy women to study the trigeminovascular system, which plays a role in migraine.
- Age
- 18 to 64 years
- Sex
- Women only
This trial only enrols healthy participants. The registry sentence this rests on: This is a study in healthy volunteers.
Read by machine on 9 Nov 2026.
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC) | Rotterdam | Netherlands | Not yet recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.